![](/img/cover-not-exists.png)
12 - Immunosuppressive (IS) therapy impacts the results of Quantiferon® and tuberculin skin test in routine screening for latent tuberculosis (LTB) in patients with inflammatory bowel diseases (IBD)
P. Papay, A. Eser, W. Miehsler, C. Lichtenberger, A. Mikulits, C. Dejaco, G. Novacek, H. Vogelsang, W. ReinischVolume:
3
Year:
2009
Language:
english
DOI:
10.1016/s1873-9946(09)60024-6
File:
PDF, 54 KB
english, 2009